← Eichor
Condition: Lymphopenia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lymphopenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 L
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05600920Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Immunological Effects of Iron Supplementation in HHT Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT07111598Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00867269Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia
Phase 3 · 1 location(s) · YiLin · NCT07202143Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06584006Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemor
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06181656Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
Phase N/A · 1 location(s) · Second Affiliated Hospital of Nanchang University · NCT07146737The Mechanistic Biology of Primary Immunodeficiency Disorders
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03394053Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04097561Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02015013
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.